Analytical performance characteristics of the cepheid GeneXpert Ebola Assay for the detection of Ebola virus

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Pinsky, Benjamin A ^a   Sahoo, Malaya K ^a   Sandlund, Johanna ^a,b   Kleman, Marika ^c   Kulkarni, Medha ^d   Grufman, Per ^c   Nygren, Malin ^c   Kwiatkowski, Robert ^d   Baron, Ellen Jo ^d   Tenover, Fred ^d   Denison, Blake ^d   Higuchi, Russell ^d   Van Atta, Reuel ^d   Beer, Neil Reginald ^e   Carrillo, Alda Celena ^e   Naraghi Arani, Pejman ^e   Mire, Chad E ^f   Ranadheera, Charlene ^g   Grolla, Allen ^g   Lagerqvist, Nina ^h   Persing, David H ^d   more..

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c Cepheid   (Sweden)

^d CEPHEID   (United States)

^e LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^f University of Texas Medical Branch School of Medicine   (United States)

^g PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^h SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ANALYTICAL EQUIPMENT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; EBOLA ASSAY; EBOLAVIRUS; HUMAN; LIMIT OF DETECTION; NONHUMAN; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION; VIRUS INACTIVATION; VIRUS PLAQUE; VIRUS TITRATION; ANIMAL; BLOOD; CHLOROCEBUS AETHIOPS; GENETICS; HEMORRHAGIC FEVER, EBOLA; HOST PATHOGEN INTERACTION; MASS SCREENING; NUCLEIC ACID AMPLIFICATION; PHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; TIME FACTOR; VERO CELL LINE; VIROLOGY; VIRUS GENE;

ANIMALS; CERCOPITHECUS AETHIOPS; EBOLAVIRUS; GENES, VIRAL; HEMORRHAGIC FEVER, EBOLA; HOST-PATHOGEN INTERACTIONS; HUMANS; MASS SCREENING; NUCLEIC ACID AMPLIFICATION TECHNIQUES; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; TIME FACTORS; VERO CELLS; VIRUS INACTIVATION;

EID: 84955499230     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0142216     Document Type: Article

References (23)

1. Feldmann H, Jones S, Klenk HD, Schnittler HJ. Ebola virus: from discovery to vaccine. Nat Rev Immunol. 2003; 3(8):677-85. doi:10.1038/nri1154 PMID: 12974482.
2. Bukreyev AA, Chandran K, Dolnik O, Dye JM, Ebihara H, Leroy EM, et al. Discussions and decisions of the 2012-2014 International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group, January 2012-June 2013. Arch Virol. 2014; 159(4):821-30. doi:10.1007/s00705-013-1846-9 PMID: 24122154; PubMed Central PMCID: PMCPMC3984924.
3. Kuhn JH, Andersen KG, Baize S, Bao Y., Bavari S, Berthet N, et al. Nomenclature-and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014. Viruses. 2014; 6(11):4760-99. Epub 2014/11/26. doi:10.3390/v6114760 PMID: 25421896; PubMed Central PMCID: PMCPmc4246247.
4. Rougeron V, Feldmann H, Grard G., Becker S, Leroy EM. Ebola and Marburg haemorrhagic fever. J Clin Virol. 2015; 64:111-9. doi:10.1016/j.jcv.2015.01.014 PMID: 25660265.
5. Towner JS, Rollin PE, Bausch D.G., Sanchez A., Crary SM, Vincent M, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol. 2004; 78(8):4330-41. PMID: 15047846; PubMed Central PMCID: PMCPMC374287.
6. Akerlund E, Prescott J, Tampellini L. Shedding of Ebola Virus in an Asymptomatic Pregnant Woman. N Engl J Med. 2015; 372(25):2467-9. doi:10.1056/NEJMc1503275 PMID: 26083224.
7. Bausch DG, Towner JS, Dowell S.F., Kaducu F., Lukwiya M, Sanchez A, et al. Assessment of the risk of Ebola virus transmission from bodily fluids andfomites. J Infect Dis. 2007; 196 Suppl 2:S142-7. doi:10.1086/520545 PMID: 17940942.
8. Foundation for Innovative New Diagnostics (FIND). Situational review of Ebola diagnostics and opportunities for rapid improvement. 2014. Available from: http://www.finddiagnostics.org/export/sites/default/resource-centre/news/pdf/eboladiagnosticssummaryv12.pdf.
9. Gupta M, MacNeil A, Reed Z.D., Rollin PE, Spiropoulou CF. Serology and cytokine profiles in patients infected with the newly discovered Bundibugyo ebolavirus. Virology. 2012; 423(2):119-24. doi:10.1016/j.virol.2011.11.027 PMID: 22197674.
10. Broadhurst MJ, Kelly JD, Miller A, Semper A, Bailey D, Groppelli E, et al. ReEBOV Antigen RapidTest kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study. Lancet. 2015; 386(9996):867-74. doi:10.1016/S0140-6736(15)61042-X PMID: 26119838.
11. Niedrig M, Schmitz H, Becker S, Gunther S, ter Meulen J, Meyer H, et al. First international quality assurance study on the rapid detection of viral agents of bioterrorism. J Clin Microbiol. 2004; 42 (4):1753-5. PMID: 15071040; PubMed Central PMCID: PMCPMC387573.
12. Raja S, Ching J, Xi L., Hughes SJ, Chang R, Wong W, et al. Technology for automated, rapid, and quantitative PCR or reverse transcription-PCR clinical testing. Clin Chem. 2005; 51(5):882-90. doi:10.1373/clinchem.2004.046474 PMID: 15746302.
13. Jones SM, Feldmann H, Stroher U., Geisbert JB, Fernando L, Grolla A, et al. Live attenuated recombinantvaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med. 2005; 11 (7):786-90. doi:10.1038/nm1258 PMID: 15937495.
14. U.S. Food and Drug Administration Emergency Use Authorizations. Emergency Use Authorizations 2015 [cited 2015 June 2]. Available from: http://www.fda.gov/MedicalDevices/Safety/EmergencySituations/ucm161496.htm.
15. Kuhn JH, Lofts LL, Kugelman J.R., Smither SJ, Lever MS, van der Groen G, et al. Reidentification of Ebola Virus E718 and ME as Ebola Virus/H.sapiens-tc/COD/1976/Yambuku-Ecran. Genome announcements. 2014; 2(6). doi:10.1128/genomeA.01178-14 PMID: 25414499; PubMed Central PMCID: PMCPMC4239354.
16. Towner JS, Sealy TK, Ksiazek TG, Nichol ST. High-throughput molecular detection of hemorrhagic fever virus threats with applications for outbreak settings. J Infect Dis. 2007; 196 Suppl 2:S205-12. doi:10.1086/520601 PMID: 17940951.
17. Trombley AR, Wachter L, Garrison J, Buckley-Beason VA, Jahrling J, Hensley LE, et al. Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses. Am J Trop Med Hyg. 2010; 82(5):954-60. doi:10.4269/ajtmh.2010.09-0636 PMID: 20439981; PubMed Central PMCID: PMCPMC2861391.
18. Gire SK, Goba A, Andersen K.G., Sealfon RS, Park DJ, Kanneh L, et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science. 2014; 345(6202):1369-72. doi:10.1126/science.1259657 PMID: 25214632; PubMed Central PMCID: PMCPMC4431643.
19. Park DJ, Dudas G, Wohl S, Goba A, Whitmer SL, Andersen KG, et al. Ebola Virus Epidemiology, Transmission, and Evolution during Seven Months in Sierra Leone. Cell. 2015; 161(7):1516-26. doi:10.1016/j.cell.2015.06.007 PMID: 26091036; PubMed Central PMCID: PMCPMC4503805.
20. Tong YG, Shi WF, Liu D, Qian J, Liang L, Bo XC, et al. Genetic diversity and evolutionary dynamics of Ebola virus in Sierra Leone. Nature. 2015; 524(7563):93-6. doi:10.1038/nature14490 PMID: 25970247.
21. Cnops L, Gerard M, Vandenberg O, Van den Wijngaert S, Heyndrickx L, Willems E, et al. Risk of Misinterpretation of Ebola Virus PCR Results: After rVSV ZEBOV-GP Vaccination. Clin Infect Dis. 2015; 60 (11):1725-6. doi:10.1093/cid/civ131 PMID: 25694650.
22. Reusken C, Niedrig M, Pas S., Anda P, Baize S, Charrel R., et al. Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014. J Clin Virol. 2015; 62:124-34. PMID: 25692204.
23. Mitchell SW, McCormick JB. Physicochemical inactivation of Lassa, Ebola, and Marburg viruses and effect on clinical laboratory analyses. J Clin Microbiol. 1984; 20(3):486-9. PMID: 6490832; PubMed Central PMCID: PMCPMC271356.